Skip to main content

Table 1 Characteristics of healthy controls and patients

From: Urinary exosome proteins PAK6 and EGFR as noninvasive diagnostic biomarkers of diabetic nephropathy

Variables

HC (nā€‰=ā€‰48)

T2DM (nā€‰=ā€‰48)

DN (nā€‰=ā€‰48)

P value

Age, years

60 (50.25ā€‰~ā€‰65.0)

58.0 (49.5ā€‰~ā€‰63.0)

61(51.25ā€‰~ā€‰66.75)

0.196

Gender, Male, n (%)

28(58.33)

28 (58.33)

28(58.33)

1.000

Hypertension, yes, n (%)

5 (10.42)

20(41.67)

36(75.0)

0.002

CHD, yes, n (%)

3(6.25)

16(33.33)

14(29.17)

0.826

Smoking history

Ā Ā Ā 

0.642

ā€ƒYes, n (%)

5 (10.41)

11 (22.92)

14 (29.67)

Ā 

ā€ƒNo, n (%)

43 (89.59)

37 (77.08)

34 (70.83)

Ā 

Drinking history

Ā Ā Ā 

1.000

ā€ƒYes, n (%)

7 (14.58)

5 (10.42)

6 (12.5)

Ā 

ā€ƒNo, n (%)

41 (85.42)

43 (89.58)

42 (87.5)

Ā 

Diabetic retinopathy

Ā Ā Ā 

<ā€‰0.001

ā€ƒYes, n (%)

NA

2(4.17)

27(56.25)

Ā 

ā€ƒNo, n (%)

NA

46(95.83)

21(47.35)

Ā 

Diabetic foot

Ā Ā Ā 

1.000

ā€ƒYes, n (%)

NA

0(0)

0(0)

Ā 

ā€ƒNo, n (%)

NA

48(100)

48(100)

Ā 

Diabetic family history

Ā Ā Ā 

0.301

ā€ƒYes, n (%)

8 (16.67)

25(47.92)

31(64.58)

Ā 

ā€ƒNo, n (%)

40 (83.33)

23(52.08)

17(35.42)

Ā 

DD, years

Ā Ā Ā 

0.146

ā€ƒ< 5 years

NA

10(21.83)

4(8.33)

Ā 

ā€ƒā‰„ā€‰5 years

NA

38(79.17)

44(91.67)

Ā 

BMI, kg/m2

22.84ā€‰Ā±ā€‰2.75

25.47ā€‰Ā±ā€‰3.42

27.02ā€‰Ā±ā€‰4.95

0.397

SBP, mm Hg

119.96ā€‰Ā±ā€‰8.32

127.0(117.5ā€‰~ā€‰138.5)

138.5ā€‰Ā±ā€‰20.24

0.023

DBP, mm Hg

75 (70.0ā€‰~ā€‰78.75)

79.58ā€‰Ā±ā€‰9.67

80.0(76.5ā€‰~ā€‰87.75)

0.187

AST, U/L

19.19ā€‰Ā±ā€‰3.05

20.0 (15.0ā€‰~ā€‰25.75)

19.5(12.0ā€‰~ā€‰28.0)

0.602

ALT, U/L

18.52ā€‰Ā±ā€‰5.59

17.0(14.0ā€‰~ā€‰20.75)

16.0 (13.0ā€‰~ā€‰20.75)

0.607

ALB, g/L

44.00ā€‰Ā±ā€‰2.32

40.16ā€‰Ā±ā€‰2.78

36.78ā€‰Ā±ā€‰2.79

<ā€‰0.001

FPG, mmol/L

5.09ā€‰Ā±ā€‰0.38

6.78 (6.02ā€‰~ā€‰8.33)

8.01 (6.66ā€‰~ā€‰11.16)

0.007

HbA1c, %

5.4 (5.2ā€‰~ā€‰5.5)

8.87ā€‰Ā±ā€‰1.90

9.41ā€‰Ā±ā€‰2.18

0.037

GA, %

9.67ā€‰Ā±ā€‰1.64

20.60 (17.25ā€‰~ā€‰28.10)

25.16ā€‰Ā±ā€‰7.31

0.101

Serum Cr, Āµmol/L

64.52ā€‰Ā±ā€‰11.57

66.0(51.25ā€‰~ā€‰69.75)

78.0 (63.0ā€‰~ā€‰91.5)

<ā€‰0.001

eGFR, mL/min/1.73m2

104.79ā€‰Ā±ā€‰9.72

100.5(95.25ā€‰~ā€‰108.75)

85.00 (63.25ā€‰~ā€‰100.5)

<ā€‰0.001

UACR, mg/g

Ā Ā Ā 

<ā€‰0.001

ā€ƒ<30

48 (100.00)

48(100.00)

0(0)

Ā 

ā€ƒā‰„ā€‰30

0 (0)

0(0)

48(100.00)

Ā 

Treatment

Ā Ā Ā 

0.003

ā€ƒInsulinā€‰+ā€‰Drugs, n (%)

NA

10(21.83)

24(50.0)

Ā 

ā€ƒDrugs, n (%)

NA

38(79.17)

24(50.0)

Ā 
  1. Note: Values are presented as meanā€‰Ā±ā€‰standard deviation, number (%), or median (interquartile range); P value: T2DM vs. DN